• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Determinants of use of oral complementary-alternative medicine among women with early breast cancer:  a focus on cancer-related fatigue
ConclusionOne-in-four patients reported use of OCAM. More severe CRF was consistently associated with its use. Moreover, older, better educated, wealthier, more anxious women, and those receiving chemotherapy seemed more prone to use OCAM. Characterizing profiles of BC patients more frequently resorting to OCAM may help deliver targeted information about its benefits and potential risks.
Source: Breast Cancer Research and Treatment - September 24, 2021 Category: Cancer & Oncology Source Type: research

Complementary and alternative medicine in sarcoma patients treated in an Italian sarcoma center
Conclusions: This study shows that CAM use is frequent among adults and pediatric patients with bone and soft tissue sarcoma as in other cancer patients. Moreover, the profile of these Italian CAM consumers in sarcoma patients is similar to other studies. Patients disclosure to their oncologist or physician about the use of CAM was similar to other Italian studies, but higher compared to other international studies.
Source: Journal of Cancer Research and Therapeutics - June 11, 2021 Category: Cancer & Oncology Authors: Alessandra Longhi Elisabetta Setola Cristina Ferrari Elisa Carretta Source Type: research

Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial
ConclusionsThe efficacy endpoint was not reached, and BRN-01 administration was not demonstrated as an efficient treatment to alleviate HF symptoms due to adjuvant ET in breast cancer patients. However, the study drug administration led to decreased HFS with a positive impact on QoL. Without any recommended treatment to treat or alleviate the HF-related disabling symptoms, Actheane ® could be a promising option, providing an interesting support for better adherence to ET, thereby reducing the risk of recurrence with a good tolerance profile.
Source: Supportive Care in Cancer - April 4, 2019 Category: Cancer & Oncology Source Type: research

A Feasibility Pilot Trial of Individualized Homeopathic Treatment of Fatigue in Children Receiving Chemotherapy
Conclusions. Trials of individualized homeopathy for fatigue reduction in pediatric cancer are not feasible in this context; lack of interest was a primary reason. Alternative approaches to evaluating homeopathy efficacy are needed.
Source: Integrative Cancer Therapies - November 16, 2016 Category: Cancer & Oncology Authors: Brule, D., Gillmeister, B., Lee, M., Alexander, S., Gassas, A., Hendershot, E., Zupanec, S., Dupuis, L., Sung, L. Tags: Research Articles Source Type: research

Abstract P2-12-03: The financial costs of metastatic breast cancer and the decisions patients make to cope with costs: Findings from the Cancer Experience Registry
Conclusion: MBC places a significant financial burden on patients, which can result in patients taking measures that can significantly impact their quality of life. Future implications for research include the development and evaluation of interventions designed to enhance doctor-patient communication and support (e.g., financial counseling) to ensure that the financial cost of MBC does not negatively impact the patient’s quality of life, course of cancer care, and health outcomes. Citation Format: Joanne Buzaglo, Anne Morris, Melissa Miller, Allison Harvey, Mitch Golant. The financial costs of metastatic breast cancer a...
Source: Cancer Research - April 30, 2015 Category: Cancer & Oncology Authors: Buzaglo, J., Morris, A., Miller, M., Harvey, A., Golant, M. Tags: Poster Session Abstracts Source Type: research

Exploring frontiers: Use of complementary and alternative medicine among patients with early-stage breast cancer.
CONCLUSION: Breast cancer patients are common users of CAM concomitantly to their conventional cancer treatments and should be investigated regarding their current consumption of CAM. Furthermore, they need advice evidence-based data on these treatments and potential interactions with on-going treatments. PMID: 24529905 [PubMed - as supplied by publisher]
Source: Breast - February 12, 2014 Category: Cancer & Oncology Authors: Saghatchian M, Bihan C, Chenailler C, Mazouni C, Dauchy S, Delaloge S Tags: Breast Source Type: research